Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Urinary proteome alterations in HER2 enriched breast cancer revealed by multipronged quantitative proteomics

21 Jun 2016

Abstract excerpt

Globally, breast cancer is the second most common cancer among women. Although biomarker discoveries through various proteomic approaches of tissue and serum samples have been studied in breast cancer, urinary proteome alterations in breast cancer are least studied. Urine being a noninvasive biofluid and a significant source of proteins, it has the potential in early diagnosis of breast cancer. This study used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Clusterin in disease pathology
Share to Metabolomics and Mass Spectrometry Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27324523
DOI: 10.1002/pmic.201600015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Urinary proteome alterations in HER2 enriched breast cancer revealed by multipronged quantitative proteomicsPMID 27324523Read ↗

Breast cancer proteomics: a review for cliniciansSemantic proximity Read ↗

Profiling protein post-translational modifications in plasma-derived extracellular vesicles as fingerprints for breast cancer subtypesSemantic proximity Read ↗

Clinical proteomics reveals vulnerabilities in non-invasive breast ductal carcinoma and drives personalized treatment strategiesSemantic proximity Read ↗

Proteomics as a Complementary Technique to Characterize Bladder CancerSemantic proximity Read ↗

Proteomics and genomics of urinary bladder cancer.Semantic proximity Read ↗

Profiling Protein Post-Translational Modifications in Plasma-derived Extracellular Vesicles as Fingerprints for Breast Cancer SubtypesSemantic proximity Read ↗

High-throughput proteomics of breast cancer subtypes: Biological characterization and multiple candidate biomarker panels to patients' stratificationSemantic proximity Read ↗

A Comprehensive Investigation toward the Indicative Proteins of Bladder Cancer in Urine: From Surveying Cell Secretomes to Verifying Urine ProteinsSemantic proximity Read ↗

Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancersSemantic proximity Read ↗

Landscaping of Urine Proteome: Unlocking Diagnostic Potential and Overcoming Unique ChallengesSemantic proximity Read ↗

Sensitive and Specific Early-Stage Breast Cancer Detection using Deep Proteome Profiling from PlasmaSemantic proximity Read ↗

Proteomic characterization of Her2/neu‐overexpressing breast cancer cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.